Tuberculosis vaccine H1IC (Valneva/Statens Serum Institut)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTuberculosis vaccine H1IC (Valneva/Statens Serum Institut)
Drug Alias NameH1IC结核疫苗 - Valneva/Statens Serum InstitutH1ICH1: IC31H1/IC31 vaccineAdjuvanted TB subunit vaccine H1IC +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntercellStatens Serum Institut
China Registration ClassN/A

Develop Information

Active CompaniesIntercellValnevaStatens Serum Institut
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A